Citation Impact
Citing Papers
Oxidative Stress
2017 Standout
Copper Chelation Enhances Antitumor Efficacy and Systemic Delivery of Oncolytic HSV
2012
Genome-wide CRISPR screens reveal a specific ligand for the glycan-binding immune checkpoint receptor Siglec-7
2021 StandoutNobel
Modulation of immune cell reactivity with cis -binding Siglec agonists
2021 StandoutNobel
Optimal Dissociation Methods Differ for N - and O -Glycopeptides
2020 StandoutNobel
Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult
2002 Standout
Haemodynamic definitions and updated clinical classification of pulmonary hypertension
2018 Standout
Oxidative Stress in Cells with Extra Centrosomes Drives Non-Cell-Autonomous Invasion
2018
Copper(I)-binding properties of de-coppering drugs for the treatment of Wilson disease. α-Lipoic acid as a potential anti-copper agent
2018
Recognizing millions of consistently unidentified spectra across hundreds of shotgun proteomics datasets
2016
Chapter 7 Cannabinoid Receptor CB1 Antagonists
2009
Phosphoproteomic comparison of Pik3ca and Pten signalling identifies the nucleotidase NT5C as a novel AKT substrate
2017
Modulation of p53, c-fos, RARE, cyclin A, and cyclin D1 expression in human leukemia (HL-60) cells exposed to arsenic trioxide
2009
Cell cycle proteins as promising targets in cancer therapy
2017 Standout
Acute Kidney Injury and Chronic Kidney Disease as Interconnected Syndromes
2014 Standout
Risk to the Breast-Fed Neonate From Codeine Treatment to the Mother: A Quantitative Mechanistic Modeling Study
2009
Cancer drug resistance: an evolving paradigm
2013 Standout
Bioactives from fruit processing wastes: Green approaches to valuable chemicals
2016 Standout
Copper in diseases and treatments, and copper‐based anticancer strategies
2009
Taming THC: potential cannabis synergy and phytocannabinoid‐terpenoid entourage effects
2011 Standout
Targeting Aurora A kinase activity with the investigational agent alisertib increases the efficacy of cytarabine through a FOXO‐dependent mechanism
2012
Morphine metabolites
1997
Bortezomib as the First Proteasome Inhibitor Anticancer Drug: Current Status and Future Perspectives
2011
Intranasal Delivery of Morphine
2002
ROS Function in Redox Signaling and Oxidative Stress
2014 Standout
Enhancing Tumor-Specific Uptake of the Anticancer Drug Cisplatin with a Copper Chelator
2010
Molecular mechanisms of cisplatin resistance
2011 Standout
Pharmacokinetics and Pharmacodynamics of Sedatives and Analgesics in the Treatment of Agitated Critically Ill Patients
1997
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
2006 Standout
Targeting apoptosis in cancer therapy
2020 Standout
The ubiquitin–proteasome system: opportunities for therapeutic intervention in solid tumors
2014
The CRIT Study: Anemia and blood transfusion in the critically ill—Current clinical practice in the United States*
2004 Standout
Tyrosine kinase inhibitors as modulators of ABC transporter-mediated drug resistance
2012
Homolog-Selective Degradation as a Strategy to Probe the Function of CDK6 in AML
2018
Modulation of Ocular Surface Glycocalyx Barrier Function by a Galectin-3 N-terminal Deletion Mutant and Membrane-Anchored Synthetic Glycopolymers
2013 StandoutNobel
Recent advances and developments in the clinical use of i.v. opioids during the peroperative period
1998
The effect of chronic renal failure on drug metabolism and transport
2008
Ontogeny of Hepatic and Renal Systemic Clearance Pathways in Infants
2002
Management of Chronic Kidney Disease Patients in the Intensive Care Unit: Mixing Acute and Chronic Illness
2017 Standout
Oxidative Stress in Cancer
2020 Standout
Drug glucuronidation in humans
1991
Crystal structure of the µ-opioid receptor bound to a morphinan antagonist
2012 StandoutNatureNobel
Understanding the Intersections between Metabolism and Cancer Biology
2017 Standout
Heavy Metal Toxicity and the Environment
2012 Standout
Drug discovery from medicinal plants
2005 Standout
A Pragmatic Guide to Enrichment Strategies for Mass Spectrometry–Based Glycoproteomics
2020 StandoutNobel
AKT/PKB Signaling: Navigating the Network
2017 Standout
The PI3K Pathway in Human Disease
2017 Standout
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Cytotoxity of nanoparticles is influenced by size, proliferation and embryonic origin of the cells used for testing
2011
The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles
2012 Standout
Association Between Pharmaceutical Support and Basic Science Research on Erythropoiesis-Stimulating Agents
2010
Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy
2012 StandoutNobel
Inflammatory bone loss: pathogenesis and therapeutic intervention
2012 Standout
Chitosan microspheres as a potential carrier for drugs
2004 Standout
Developmental Pharmacology — Drug Disposition, Action, and Therapy in Infants and Children
2003 Standout
Redox-Directed Cancer Therapeutics: Molecular Mechanisms and Opportunities
2009
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
The PI3K/mTOR inhibitor PF-04691502 induces apoptosis and inhibits microenvironmental signaling in CLL and the Eµ-TCL1 mouse model
2015
Development of an injectable sustained-release formulation of morphine: antinociceptive properties in rats
1998
Chronic Kidney Disease Diagnosis and Management
2019 Standout
Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen Heterocycles among U.S. FDA Approved Pharmaceuticals
2014 Standout
Inhibition of NGLY1 Inactivates the Transcription Factor Nrf1 and Potentiates Proteasome Inhibitor Cytotoxicity
2017 StandoutNobel
Fundamentals of cancer metabolism
2016 Standout
Targeting SOD1 reduces experimental non–small-cell lung cancer
2013
The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences
2021 Standout
Picking the Point of Inhibition: A Comparative Review of PI3K/AKT/mTOR Pathway Inhibitors
2014 Standout
Galectin-Binding O-Glycosylations as Regulators of Malignancy
2015
Human UGT2B7 catalyzes morphine glucuronidation.
1997
Pharmacokinetics Anesthesiologists, and Pharmacodynamics of Remifentanil in Persons with Renal Failure Compared with Healthy Volunteers
1997
The role of erythropoietin and its receptor in growth, survival and therapeutic response of human tumor cells
2010
Strategies for the Optimization of Natural Leads to Anticancer Drugs or Drug Candidates
2015
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Galectin-3 binds to CD45 on diffuse large B-cell lymphoma cells to regulate susceptibility to cell death
2012
Human UDP-Glucuronosyltransferases: Metabolism, Expression, and Disease
2000 Standout
Reactive species in non-equilibrium atmospheric-pressure plasmas: Generation, transport, and biological effects
2016 Standout
Copper induces cell death by targeting lipoylated TCA cycle proteins
2022 StandoutScience
The bioactivity of modified pectin fragments
2013
The glucuronidation of opioids, other xenobiotics, and androgens by human UGT2B7Y(268) and UGT2B7H(268).
1998
Traditional and complementary medicine used with curative intent in childhood cancer: A systematic review
2017
Phosphoproteomics in the Age of Rapid and Deep Proteome Profiling
2015
Acute Heroin Overdose
1999
Advances in Copper Complexes as Anticancer Agents
2013 Standout
Plant Secondary Metabolites as Anticancer Agents: Successes in Clinical Trials and Therapeutic Application
2018 Standout
Targeting PI3K in Cancer: Impact on Tumor Cells, Their Protective Stroma, Angiogenesis, and Immunotherapy
2016
Chemical Inhibition of ENL/AF9 YEATS Domains in Acute Leukemia
2021 StandoutNobel
Morphine-6-Glucuronide
2001
Chitosan Chemistry and Pharmaceutical Perspectives
2004 Standout
Industry sponsorship and research outcome
2017 Standout
Novel Thiosemicarbazones of the ApT and DpT Series and Their Copper Complexes: Identification of Pronounced Redox Activity and Characterization of Their Antitumor Activity
2010
Works of Simon Joel being referenced
A Synergistic Interaction between Lapatinib and Chemotherapy Agents in a Panel of Cell Lines Is Due to the Inhibition of the Efflux Pump BCRP
2010
AZD1152 Rapidly and Negatively Affects the Growth and Survival of Human Acute Myeloid Leukemia Cells In vitro and In vivo
2009
Phosphoproteomics data classify hematological cancer cell lines according to tumor type and sensitivity to kinase inhibitors
2013
The pharmacokinetics of morphine and morphine glucuronides in kidney failure
1993
Bortezomib, low‐dose intravenous melphalan, and dexamethasone for patients with relapsed multiple myeloma
2009
The comparative clinical pharmacology of vincristine and vindesine: Does vindesine offer any advantage in clinical use?
1995
Enhancing thein vitrocytotoxic activity of Δ9-tetrahydrocannabinol in leukemic cells through a combinatorial approach
2008
Effect of haemopoietic growth factors on cancer cell lines and their role in chemosensitivity
2003
Kinase-Substrate Enrichment Analysis Provides Insights into the Heterogeneity of Signaling Pathway Activation in Leukemia Cells
2013
Phase I Study of Copper-Binding Agent ATN-224 in Patients with Advanced Solid Tumors
2008
GCS-100, a novel galectin-3 antagonist, modulates MCL-1, NOXA, and cell cycle to induce myeloma cell death
2010
Cannabis-induced cytotoxicity in leukemic cell lines: the role of the cannabinoid receptors and the MAPK pathway
2004
Morphine and metabolite behavior after different routes of morphine administration: Demonstration of the importance of the active metabolite morphine-6-glucuronide
1990
P110α-mediated constitutive PI3K signaling limits the efficacy of p110δ-selective inhibition in mantle cell lymphoma, particularly with multiple relapse
2013